[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361270-105":59,"doc-detail-361270-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","igf2bp1-mediated-ma-modification-stabilizes-hmga2-mrna-to-promote-intrahepatic-cholangiocarcinoma-progression","IGF2BP1-Mediated m⁶A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma Progression","","We identify high-mobility group protein A2 (HMGA2) as a key oncogenic driver of intrahepatic cholangiocarcinoma growth and metastasis. Insulin-like growth factor 2 messenger RNA-binding protein 1 (IGF2BP1) positively regulates HMGA2 expression through m6A modification, promoting PI3K–AKT pathway activation. Integrated analyses across multiple independent cohorts and functional studies in iCCA cell lines and several mouse models show HMGA2 depletion suppresses proliferation, migration, tumor growth, and metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/igf2bp1-mediated-ma-modification-stabilizes-hmga2-mrna-to-promote-intrahepatic-cholangiocarcinoma-progression/361270/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/igf2bp1-mediated-ma-modification-stabilizes-hmga2-mrna-to-promote-intrahepatic-cholangiocarcinoma-progression/361270.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does HMGA2 play in intrahepatic cholangiocarcinoma?","Question",{"text":112,"@type":113},"HMGA2 is upregulated in intrahepatic cholangiocarcinoma and correlates with poor survival. Functional studies show HMGA2 depletion suppresses iCCA cell proliferation, migration, tumor growth, and metastasis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does IGF2BP1 regulate HMGA2?",{"text":117,"@type":113},"IGF2BP1 stabilizes HMGA2 messenger RNA via N6-methyladenosine-dependent binding, involving KH3-4 domains. This forms the IGF2BP1–HMGA2 axis that drives disease progression.",{"name":119,"@type":110,"acceptedAnswer":120},"Which signaling pathway is activated by the IGF2BP1–HMGA2 axis?",{"text":121,"@type":113},"The axis promotes activation of the PI3K–AKT pathway in intrahepatic cholangiocarcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361270,1791176924,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","ORIGINAL RESEARCH   \nIGF2BP1-Mediated m⁶A Modification Stabilizes HMGA2 mRNA to   Promote Intrahepatic Cholangiocarcinoma Progression  \nYu Guo, 1 ,2 ,* Le Zhu,2 ,* Kaiheng Hu,3 ,* Xiangyu Wang,1 Sanfeng Han,2 Meiping Ni,2 Jixuan Chen,1 Keyu Shen, 1 Qimeng Chang,2 Chengjie Zhang,4 Mingxiu Cai,3 Hong Cheng,5 Chaoqun Wang,1 Haoting Sun, 1 and Qiongzhu Dong1 ,2  \n1Department of General Surgery, Hepatobiliary Surgery Center, Huashan Hospital and Cancer Metastasis Institute, Fudan University, Shanghai, China; 2Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer, Shanghai Municipal Health Commission, Minhang Hospital, Fudan University, Shanghai, China; 3Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; 4College of Acupuncture-Moxibustion, Anhui University of Chinese Medicine, Hefei, Anhui, China; and 5Department of Medical Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \nSUMMARY  \nWe identify high-mobility group protein A2 (HMGA2) as a key oncogenic driver of intrahepatic cholangiocarcinoma growth and metastasis. Insulin-like growth factor 2 messenger RNA-binding protein 1 (IGF2BP1) positively regulates HMGA2 expression via m6A modification, with the IGF2BP1–HMGA2 axis promoting PI3K–AKT pathway activation in intrahepatic cholangiocarcinoma, highlighting a promising therapeutic strategy.  \nBACKGROUND & AIMS: Intrahepatic cholangiocarcinoma (iCCA) remains a lethal malignancy with a lack of effective therapies, underscoring the critical need to identify novel therapeutic targets. The high-mobility group protein A2 (HMGA2) is an oncogenic architectural transcription factor aberrantly overexpressed in multiple cancers; yet its function and regulatory mechanisms in iCCA are poorly defined. This study aimed to elucidate the clinical significance and molecular mechanism of HMGA2 in iCCA progression.  \nMETHODS: We integrated analyses across 4 independent iCCA cohorts (The Cancer Genome Atlas, 2 Zhongshan Hospital cohorts, and our 192-patient institutional cohort). Functional investigations were conducted using iCCA cell lines and multiple mouse models, including xenograft, syngeneic, YAP/AKT-driven spontaneous iCCA, and metastasis models.  \nRESULTS: We demonstrated that HMGA2 was significantly upregulated in iCCA, correlating with poor survival, and exhibited sexually dimorphic prognostic effects with a female-specific link to  \nWHAT YOU NEED TO KNOW  \nBackground: Intrahepatic cholangiocarcinoma (iCCA) is a lethal cancer with limited therapies. High-mobility group protein A2 (HMGA2) overexpression is linked to poor prognosis, but its role and regulation in iCCA progression remain unclear.  \nImpact: We identify HMGA2 as a key driver of iCCA progression. The N6-methyladenosine reader insulin-like growth factor 2 messenger RNA-binding protein 1 (IGF2BP1) stabilizes HMGA2 messenger RNA, defining the IGF2BP1–HMGA2 axis as a novel prognostic biomarker and promising therapeutic target.  \nFuture Directions: Future studies will prioritize developing novel inhibitors targeting the IGF2BP1–HMGA2 axis, systematically evaluate their synergistic potential with standard therapies, and validate clinical efficacy in largescale cohorts of patients with iCCA.  \nperineural invasion. Functionally, HMGA2 depletion suppressed iCCA cell proliferation, migration, in vivo tumor growth and metastasis. Mechanistically, HMGA2 expression was positively regulated by the N6-methyladenosine reader insulin-like growth factor 2 messenger RNA-binding protein 1 (IGF2BP1), which directly bound to and stabilized HMGA2 messenger RNA via its KH3-4 domains in an N6-methyladenosine–dependent manner. High IGF2BP1 expression predicted poor iCCA prognosis, was required for HMGA2–driven progression, and the axis promoted PI3K-AKT pathway activation.  \nCONCLUSIONS: Our results revea","cbCailVKiBO2TFVj","https://ap.wps.com/l/cbCailVKiBO2TFVj","pdf",28649779,27,"English","# Summary\n# Background & Aims\n# Methods\n# Results\n# What You Need to Know\n# Conclusions\n# Keywords","[{\"question\":\"What role does HMGA2 play in intrahepatic cholangiocarcinoma?\",\"answer\":\"HMGA2 is upregulated in intrahepatic cholangiocarcinoma and correlates with poor survival. Functional studies show HMGA2 depletion suppresses iCCA cell proliferation, migration, tumor growth, and metastasis.\"},{\"question\":\"How does IGF2BP1 regulate HMGA2?\",\"answer\":\"IGF2BP1 stabilizes HMGA2 messenger RNA via N6-methyladenosine-dependent binding, involving KH3-4 domains. This forms the IGF2BP1–HMGA2 axis that drives disease progression.\"},{\"question\":\"Which signaling pathway is activated by the IGF2BP1–HMGA2 axis?\",\"answer\":\"The axis promotes activation of the PI3K–AKT pathway in intrahepatic cholangiocarcinoma.\"}]","IGF2BP1-Mediated m⁶A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma Progression | PDF",1790143762,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3489bfa1bea0341535c08e577c6a451.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/523537df9b9c7772049fba76295a8cc8.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d17a5817a3d1153c25bc091d0aab5e1.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8b3184605b037a11a14704e469308cc.webp",980,1292]